Published ,
Reading 1 min.
The Nice University Hospital wants to work on early lung cancer screening. For this, a team of researchers from the hospital center is launching a study that will involve 2,600 patients. A hope to detect this disease which affects 33,000 people each year.
The objective of these researchers is simple: they want to develop tools that will better detect the onset of lung cancer, in order to treat it as soon as possible.
A study on 2600 people that will last 5 years
We told you about it recently, the High Authority for Health (HAS) recently issued an opinion which “encourages the setting up of experiments” in lung cancer screening. Professor Paul Hofman’s team and himself therefore wish to relaunch a study on the subject, which will include 2,600 people throughout France for a period of 5 years. The scientist and his team had already undertaken a similar project a few years ago, between 2015 and 2017, with the development of a blood test, which ultimately did not bear fruit.
A protocol that combines three techniques
This new protocol, carried out in partnership with the National Cancer Institute and the pharmaceutical group AstraZeneca, has received the green light from the HAS but is still awaiting authorization from the ethics committee. It will be based on a search for cancer biomarkers present in the blood, but also on a chest scanner.
To obtain the results, all the data will be entered into an artificial intelligence program, so that the algorithm can also improve diagnoses.
Consult an oncologist online
Generalized screening and reimbursed by Social Security?
The launch of this study is scheduled for next June, for a total duration of five years. At the end of this deadline, the researchers hope for conclusive results in order to achieve a screening similar to that of colorectal cancer, widely used and reimbursed by Social Security.